Recently transitioned from compounded cream → injectable TRT.

[mcs]

65 y/o | 165 lbs | 5’6” | ~10–12% BF

Recently transitioned from compounded cream → injectable TRT.

• Reason: DHT spiking and unstable serum levels.
• Current protocol: Test E in MCT oil, 11 units ED (~21 mg), ~150 mg/week total, subq/IM microdosing. Plan: 6 weeks → labs → add Deca 50 mg/week for joint relief/inflammation.

Androgen-related labs comparison:

June 2025 (on cream, peak; applied 2h prior ):

• TT: 1034 ng/dL
• Free T: 191.6 pg/mL (H)
• SHBG: 52
• DHT: 144 ng/dL (H)
• Estradiol: 46 pg/mL (H)
• LH: 2.4 / FSH: 4.2
• Prolactin: n/a

Sept 2025 (cream → pre-injectable):

• TT: 318–459 ng/dL (applied 12h prior)
• Free T: 61.5–70.7 pg/mL (↓)
• SHBG: 36–39
• DHT: 122–145 ng/dL (still high)
• Free DHT: 9.32 pg/mL (H)
• Estradiol (ultrasensitive): 24 pg/mL (normalized)
• LH: 0.6–0.8 (L) / FSH: 1.0 (L) → HPTA suppressed
• Prolactin: 6.7–6.9 ng/mL

Observations:

• On cream: supraphysiological TT/FT + elevated E2 + high DHT.
• By Sept: TT/FT crashed, gonadotropins suppressed, E2 normalized, but DHT stayed elevated.
• Prolactin baseline looks safe to trial low-dose nandrolone.

Questions for the group:

• Experiences pivoting from transdermal to daily microdosed injections (stability, labs, symptom changes)?
• Anyone add low-dose Deca (50–100 mg/week) for joints — what benefits/downsides did you see?
• Best strategies you’ve used to keep DHT in check post-cream transition?

---